At a glance
ClinicalIndex Comparison RecordPhase 4Unknown· 80 enrolled
Drug / intervention
Sugammadex +1 moredrug
Likely dose
Sugammadex 2mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of the Effectiveness of Rocuronium - Sugammadex With Succinylcholine-Cisatracurium-Neostigmine in Patients Undergoing Laser Microlaryngeal Surgery
In Brief
A Phase 4 clinical trial evaluating Sugammadex and Neostigmine for Muscle Relaxation. Targeting 80 participants.
Detailed Summary
This study is comparing of rocuronium-sugammadex and succinylcholine during LMS surgery that is characterized by short operation time, required intense paralysis and ambulatory setting, has not been investigated.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscle Relaxation
Countries--
Collaborators--
Timeline
Phase 4UnknownOverdue
201520162017201820192020202120222023202420252026
First PostedJan 2015
Enrollment StartFeb 2015
Primary CompletionAug 2015
Study CompletionSep 2016
TodayJul 2026
First PostedJan 1, 2015
Enrollment StartFeb 1, 2015
Primary CompletionAug 1, 2015
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.5 years ago
Interventions
Sugammadexdrug
Sugammadex 2mg/kg was injected to patients to R-S group, as reversal of neuromuscular blockade.
Neostigminedrug
Neostigmine (pyridostigmine) 0.2 mg/kg mg was injected to patients to S-C-N group, as reversal of neuromuscular blockade.